In the BioHarmony Drug Report Database

"Preview" Icon

Levobetaxolol

Betaxon (levobetaxolol) is a small molecule pharmaceutical. Levobetaxolol was first approved as Betaxon on 2000-02-23. It is used to treat ocular hypertension and open-angle glaucoma in the USA. The pharmaceutical is active against beta-1 adrenergic receptor. In addition, it is known to target beta-2 adrenergic receptor.

 

Trade Name

 

Betaxon
 

Common Name

 

levobetaxolol
 

ChEMBL ID

 

CHEMBL1201274
 

Indication

 

ocular hypertension, open-angle glaucoma
 

Drug Class

 

Beta-blockers (propranolol type)

Image (chem structure or protein)

Levobetaxolol structure rendering